NEW YORK (GenomeWeb) – Agilent Technologies said that the aggregate commitments under a credit facility forged last year have been increased to $700 million from $400 million. 

In a document filed with the US Securities and Exchange Commission on Wednesday, Agilent added that under the agreement reached in September 2014 with BNP Paribas as the administrative agent, it will retain the rights to further increase commitments under the five-year unsecured credit facility on one or more occasions by up to an aggregate of $300 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.